How is Esmolol administered in clinical settings?

Esmolol is administered intravenously in clinical settings due to its pharmacokinetic properties, which allow for rapid onset and easy titration of dosage. Being an ultra-short-acting beta-blocker, it is frequently used in acute situations such as the management of tachycardia, hypertension, or perioperative situations. The intravenous administration allows healthcare providers to quickly adjust the dose according to the patient’s response, making it particularly useful in emergency care.

This route of administration bypasses the digestive system, ensuring that the medication takes effect almost immediately, which is crucial in critical care scenarios. Other routes such as oral, subcutaneous, or inhalation are not utilized for Esmolol due to factors like slower absorption rates, varying bioavailability, or the specific therapeutic needs that the intravenous route fulfills.